Lip Filler Market & Treatment Trends
Lip Filler Market: Trends, Brands & What’s Ahead
Lip filler remains one of the largest applications within aesthetic injectables, but the category is becoming more precise. Patients and providers now have several FDA-approved hyaluronic acid products designed specifically for lip augmentation, while product selection increasingly depends on anatomy, movement, desired projection and treatment goals rather than simply choosing the newest brand.
Lip filler remains a major part of the injectable market. ASPS reported that lip augmentation represented 23% of soft-tissue and hyaluronic acid filler treatments in its 2025 data. The latest directly reported U.S. procedure count was 1,449,565 lip-augmentation treatments with injectable materials in 2024. The market is increasingly defined by product-specific FDA indications, anatomy-based treatment planning and a wider range of HA formulations rather than one universal “best” lip filler.
Important:
A filler being FDA-approved in the United States does not automatically mean it is FDA-approved for the lips. Approval is product- and treatment-area specific.
Lip filler has moved well beyond the idea of simply making lips larger. Modern treatment may focus on border definition, projection, symmetry, vertical height, perioral lines, age-related volume change or subtle proportion. That shift matters because the best product for one lip may not be the best product for another.
How Large Is the Lip Filler Market?
Commercial research firms frequently publish dollar estimates for the “lip filler market,” but those numbers vary substantially depending on what is included. Some reports measure product sales, some include all lip-augmentation injectables, and others extrapolate from the wider dermal filler industry.
For a clinical article, procedure data are more useful.
The American Society of Plastic Surgeons reported that soft-tissue and hyaluronic acid fillers represented 30% of minimally invasive treatments in its 2025 data. Within that filler category, 23% of treatments involved lip augmentation.
ASPS did not publish an estimated national procedure count for minimally invasive treatments in 2025 because it is revising the data source used for that category.
The last directly reported ASPS count is therefore 2024, when the organization estimated 1,449,565 lip-augmentation procedures using injectable materials in the United States.
That number was slightly higher than the 1,439,291 procedures reported for 2023.
How Does Lip Filler Fit Into the Global Filler Market?
Global data are usually reported for hyaluronic acid fillers as a category rather than lip filler alone.
The latest completed ISAPS Global Survey estimated approximately 6.34 million hyaluronic acid filler procedures worldwide in 2024, an increase of 5.2% from 2023.
Hyaluronic acid remained the second most commonly performed nonsurgical procedure worldwide after botulinum toxin.
Those 6.34 million procedures include many facial treatment areas, so they should not be described as 6.34 million lip injections. The figure is useful because it shows the scale of the HA filler category in which lip augmentation operates.
Which Lip Fillers Are Actually FDA-Approved for the Lips?
This is where the original version of this article needed the largest correction.
A product can be an FDA-approved dermal filler without having an FDA-approved lip indication. The current U.S. lip-filler landscape includes several products specifically approved for lip augmentation.
| Product | FDA-approved lip use | Practical treatment role |
|---|---|---|
| Juvéderm Ultra XC | Lip and perioral augmentation in adults over 21 | Volume, projection and shape depending on anatomy and dose |
| Juvéderm Volbella XC | Lip augmentation and correction of perioral lines in adults over 21 | Subtle volume, border refinement and perioral-line treatment |
| Restylane-L | Lip augmentation in patients over 21 | Structure and definition with an established HA formulation |
| Restylane Silk | Lip augmentation and correction of perioral rhytids in patients over 21 | Fine detail and perioral correction |
| Restylane Kysse | Lip augmentation and correction of upper perioral rhytids in patients over 21 | Shape and volume in a highly mobile area |
| Revanesse Lips+ | Lip augmentation in patients age 22 and older | HA-based lip enhancement and contouring |
This is not an exhaustive list of every HA filler available in the United States. It is a list of major products with specific FDA lip-augmentation indications.
For a broader comparison of HA filler families, see Juvéderm vs. Restylane.
Is Evolysse a Lip Filler?
Not under its current FDA indication.
Evolysse Smooth and Evolysse Form were approved by the FDA in February 2025 for dermal and subdermal injection to correct moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds, in adults age 22 and older.
The approval does not include lip augmentation.
This is an important distinction because articles describing “new filler brands” can easily create the impression that every new HA product can be marketed for lips. FDA indications are specific.
The same principle applies to other HA filler families. A product may have approval for folds, cheeks, chin or another facial area without having an approved lip indication.
Why There Is No Single “Best Lip Filler”
Comparing lip fillers only by brand overlooks the factors that actually affect the result.
Hyaluronic acid gels vary in elasticity, cohesivity, viscosity and how they behave under movement. The lips are highly mobile, so product behavior under smiling, speaking and pursing matters.
A provider should also assess:
- existing upper-to-lower lip proportion
- lip projection from the side
- vertical lip height
- border definition
- Cupid’s bow anatomy
- asymmetry
- age-related volume loss
- perioral lines
- previous filler
- chin and lower-face proportion
The product should follow the anatomy and treatment goal. Brand preference should come later.
The More Useful Lip Filler Trend: Better Planning, Not Simply More Volume
Online discussions often describe lip-filler trends in terms such as “Russian lips,” “microdosing,” “doll lips” or “natural lips.” Those terms can change quickly and may describe technique or aesthetic preference rather than a standardized medical treatment.
A more durable clinical trend is toward proportion-based planning.
Some patients need additional volume. Others mainly need border refinement or correction of asymmetry. In another patient, adding more lip projection can make an under-projected chin look less balanced.
This is why lip filler increasingly fits into a broader facial assessment rather than functioning as an isolated syringe purchase.
More filler is not inherently better, and using less product is not inherently more sophisticated. The correct amount is the amount that fits the anatomy and stated goal.
Why Staged Lip Filler Can Make Sense
A staged approach can be useful when a patient is receiving filler for the first time, wants a subtle change or has uncertain asymmetry.
Immediately after injection, swelling can temporarily exaggerate size and distort symmetry. Making additional treatment decisions before the initial swelling settles can therefore lead to unnecessary correction.
For some patients, the more predictable approach is:
- establish the treatment goal and baseline anatomy
- place a conservative amount where appropriate
- allow swelling to settle
- reassess the actual result
- add more only if the anatomy and goal still justify it
This does not mean every patient needs multiple appointments. It means the treatment plan should allow enough time to distinguish swelling from the actual result.
Lip Filler vs. Lip Flip
A lip flip is often mentioned alongside lip filler, but they are not equivalent treatments.
Lip filler adds material and can change volume, projection, contour and structure.
A lip flip uses botulinum toxin to relax selected fibers of the upper lip muscle so that a small amount of additional pink lip may become visible when the lip turns slightly outward.
A lip flip does not add filler volume and cannot create the structural changes available with HA filler.
The two treatments can therefore suit different concerns rather than functioning as interchangeable competitors.
How Long Do Lip Fillers Last?
There is no universal duration for “lip filler.” Longevity depends on the specific product, amount injected, anatomy, movement and individual metabolism.
FDA clinical studies and manufacturer labeling differ by product. Several commonly used HA lip fillers have evidence supporting results around one year in some patients, but that does not mean every treated lip will look unchanged for twelve months.
The visible result usually fades gradually rather than disappearing on one date.
For that reason, claims such as “all lip filler lasts 18 months” or “this brand always lasts longer” should be treated cautiously unless they refer to a specific product, treatment area and study.
Lip Filler Safety: What Matters Most?
Lip fillers are medical devices, not ordinary cosmetic products.
The FDA identifies unintended injection into a blood vessel as the most serious filler complication. Vascular occlusion can interrupt blood flow and cause tissue necrosis. In rare cases, filler injected into or around blood vessels can be associated with visual abnormalities including blindness, stroke and other serious injuries.
More common temporary reactions can include:
- swelling
- bruising
- tenderness
- redness
- firmness
- temporary lumps or irregularity
Delayed inflammatory reactions, infection, nodules and other complications can also occur.
HA filler has an important advantage when reversal is medically appropriate: hyaluronidase can often be used to reduce or dissolve hyaluronic acid. Hyaluronidase use for cosmetic filler dissolution is itself off-label, and reversal should not be treated as a guarantee that every complication or aesthetic concern can be completely undone.
For a detailed provider checklist, see How to Choose an Injectables Provider in the South Bay.
Current Lip Filler Pricing at Skin Works
Current standard Torrance pricing varies by the exact HA product selected.
| Current lip filler option | Price | FDA lip indication |
|---|---|---|
| Juvéderm Ultra XC | $600 | Yes |
| Juvéderm Volbella XC | $750 | Yes |
| Restylane | $600 | Restylane-L has an FDA lip-augmentation indication |
| Restylane Silk | $650 | Yes |
| Restylane Kysse | $750 | Yes |
| Revanesse Lips+ | $700 | Yes |
Pricing should not determine the product before the consultation. Two HA fillers at similar prices may behave differently and have different approved indications.
For the current service menu and treatment details, see Lip Fillers in Torrance at Skin Works.
What Is Ahead for the Lip Filler Market?
More product-specific decision making
As the number of HA formulations grows, providers will increasingly need to explain why a particular gel was selected rather than simply naming a brand.
More scrutiny of FDA indications
The Evolysse example illustrates why this matters. New product approval does not necessarily mean approval for the lips. Consumers are becoming more able to verify those distinctions through FDA labeling.
Greater emphasis on facial proportion
Lips are part of the lower face, not an isolated feature. Chin projection, dental support, philtral length and surrounding facial structure can affect whether additional lip volume improves overall balance.
Continued dominance of HA
Hyaluronic acid remains particularly useful for lips because it offers immediate contouring, several lip-specific FDA-approved products and the ability to use hyaluronidase when reversal is appropriate.
Less value in trend-chasing
Technique names and social-media aesthetics will continue to change. Anatomy, product properties, safety and proportional planning are more durable standards for deciding what should actually be injected.
The meaningful direction is more precise product selection, better understanding of facial proportion and clearer distinction between what a product is approved to do and what is simply being marketed online.
Frequently Asked Questions
Are lip fillers still popular?
Yes. ASPS reported that lip augmentation represented 23% of soft-tissue and hyaluronic acid filler treatments in its 2025 data. In 2024, ASPS estimated 1,449,565 lip-augmentation procedures using injectable materials in the United States.
What is the most common type of lip filler?
Hyaluronic acid is the dominant material used for modern temporary lip fillers. Multiple FDA-approved HA products are available specifically for lip augmentation.
Which lip filler brand is best?
There is no universally best brand. Juvéderm Ultra XC, Volbella XC, Restylane-L, Restylane Silk, Restylane Kysse and Revanesse Lips+ all have FDA-approved lip indications. Product selection should follow anatomy and treatment goals.
Is Evolysse FDA-approved for the lips?
No. Evolysse Form and Smooth are FDA-approved for correction of moderate to severe dynamic facial wrinkles and folds such as nasolabial folds. Their current FDA indication does not include lip augmentation.
Is lip filler permanent?
No. The commonly used HA lip fillers discussed in this article are temporary. Duration varies by product, dose, anatomy and individual metabolism.
Can HA lip filler be dissolved?
Hyaluronidase can often be used to reduce or dissolve HA filler when clinically appropriate. Cosmetic filler dissolution with hyaluronidase is off-label and does not guarantee restoration of the exact pre-treatment appearance.
Is a lip flip the same as lip filler?
No. Lip filler adds physical volume and structure. A lip flip uses botulinum toxin to alter selected muscle activity and does not add volume.
How much does lip filler cost at Skin Works?
Current Torrance prices for major lip products range from $600 for Juvéderm Ultra XC or Restylane to $750 for products such as Juvéderm Volbella XC and Restylane Kysse. The appropriate product should be selected based on anatomy and treatment goals rather than price alone.
Sources & Medical References
- American Society of Plastic Surgeons: 2025 Plastic Surgery Statistics
- ASPS: 2024 Lip Augmentation Procedure Statistics
- ISAPS: 2024 Global Survey on Aesthetic Procedures
- U.S. FDA: Dermal Fillers, Approved Uses and Risks
- FDA: Juvéderm Ultra XC Lip Augmentation Indication
- FDA: Juvéderm Volbella XC Lip Augmentation Indication
- FDA: Restylane Kysse Lip Augmentation Indication
- FDA: Restylane Silk Lip Augmentation Indication
- FDA: Restylane-L Lip Augmentation Indication
- FDA: Revanesse Lips+ Lip Augmentation Indication
- FDA: Evolysse Form and Smooth Approved Indication
FDA approval is product- and treatment-area specific. The presence of a filler brand on the U.S. market does not mean every product within that family is approved for lip augmentation. Procedure statistics from ASPS and ISAPS use different methodologies and should not be combined into a single market estimate. This article is educational and does not replace individualized medical care.